State Street Corp Has $4.88 Million Position in Natera, Inc. (NTRA)
State Street Corp lifted its stake in shares of Natera, Inc. (NASDAQ:NTRA) by 11.8% during the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 448,708 shares of the medical research company’s stock after purchasing an additional 47,405 shares during the quarter. State Street Corp owned 0.84% of Natera worth $4,875,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in NTRA. Alliancebernstein L.P. raised its stake in shares of Natera by 5.6% during the 1st quarter. Alliancebernstein L.P. now owns 26,600 shares of the medical research company’s stock valued at $236,000 after purchasing an additional 1,400 shares during the period. TIAA CREF Investment Management LLC raised its stake in shares of Natera by 14.3% during the 1st quarter. TIAA CREF Investment Management LLC now owns 93,901 shares of the medical research company’s stock valued at $833,000 after purchasing an additional 11,743 shares during the period. Vanguard Group Inc. raised its stake in shares of Natera by 4.4% during the 1st quarter. Vanguard Group Inc. now owns 2,007,708 shares of the medical research company’s stock valued at $17,808,000 after purchasing an additional 84,144 shares during the period. Geode Capital Management LLC raised its stake in shares of Natera by 4.8% during the 1st quarter. Geode Capital Management LLC now owns 235,287 shares of the medical research company’s stock valued at $2,086,000 after purchasing an additional 10,813 shares during the period. Finally, Renaissance Technologies LLC increased its stake in Natera by 28.2% in the 1st quarter. Renaissance Technologies LLC now owns 411,400 shares of the medical research company’s stock worth $3,649,000 after acquiring an additional 90,600 shares during the last quarter. Institutional investors own 66.19% of the company’s stock.
Natera, Inc. (NTRA) opened at $9.50 on Wednesday. The company has a debt-to-equity ratio of 2.43, a current ratio of 1.85 and a quick ratio of 1.75. Natera, Inc. has a one year low of $7.35 and a one year high of $14.76.
Natera (NASDAQ:NTRA) last announced its earnings results on Wednesday, November 8th. The medical research company reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.47) by ($0.04). The business had revenue of $56.66 million during the quarter, compared to the consensus estimate of $55.31 million. Natera had a negative return on equity of 197.09% and a negative net margin of 62.34%. Natera’s revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.50) earnings per share. equities research analysts predict that Natera, Inc. will post -2.15 EPS for the current year.
A number of equities analysts have weighed in on NTRA shares. Zacks Investment Research upgraded Natera from a “sell” rating to a “hold” rating in a research note on Friday, September 22nd. Morgan Stanley restated an “overweight” rating and issued a $16.00 target price (up from $13.00) on shares of Natera in a research note on Friday, October 6th. Canaccord Genuity restated a “buy” rating and issued a $15.00 target price on shares of Natera in a research note on Tuesday, November 14th. Robert W. Baird restated a “buy” rating on shares of Natera in a research note on Tuesday, October 24th. Finally, BidaskClub upgraded Natera from a “sell” rating to a “hold” rating in a research note on Wednesday, August 23rd. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average target price of $15.00.
Natera Company Profile
Receive News & Ratings for Natera Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.